Home Clinical Trial Updates Page 24

Clinical Trial Updates

Clinical trial updates

Phase 2b Study Investigates NFX-179 for the Treatment of Cutaneous Neurofibromas

Danielle Garcia - January 10, 2023

Capivasertib plus Fulvestrant Shows Statistically Significant and Clinical Improvement in PFS

Attendees during morning sessions of the 2018 San Antonio Breast cancer Symposium. Courtesy 2018 AACR

Updated Interim Analysis of Phase 3 monarchE Trial: Abemaciclib Shows Absolute Improvement in IDFS

ASH 2022: Positive OS Data for Patients in R/R AML in Phase 1 Actimab-A + CLAG-M Combination Trial

Active Surveillance May be an Effective Option for Low-risk Thyroid Cancer

Ganetespib Displayed Greater Antitumor Activity and Prolonged Survival in ALK-positive NSCLC...

Editorial Team - March 26, 2013

March Madness: Colorectal Cancer Prevention and Screening

Editorial Team - March 26, 2013

Study Links Higher Soy Consumption in Nonsmoking Chinese Women Before Lung...

Editorial Team - March 25, 2013

Updated Consensus Guidelines Released for Managing Abnormal Cervical Cancer Screening Tests...

Editorial Team - March 21, 2013

Higher Costs and Greater Risk for Cancer Patients Due to Drug...

Editorial Team - March 21, 2013

Results of Phase III Trial with Talimogene Laherparepvec (T-VEC) in Melanoma...

Editorial Team - March 19, 2013

Abiraterone Acetate Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) is...

Editorial Team - March 18, 2013

European Study Shows Kiva? Implant to be Effective in Treating Severe...

Editorial Team - March 18, 2013

Ruxolitinib-data Shows Significantly Reduced Myelofibrosis Disease Burden and Suggest Overall Survival...

Sonia Portillo - December 12, 2012

Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) Shows Prolonged Progression Free...

Sonia Portillo - December 11, 2012

1...232425 26 Page 24 of 26

LATEST NEWS

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Editorial Team - March 13, 2023

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

Danielle Garcia - February 27, 2023

FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors

Editorial Team - February 27, 2023

Finding a Cure for Nonalcoholic Fatty Liver Disease

Editorial Team - February 23, 2023

Why Do Politicians Weaponize Medicare? Because It Works!

Julie Rovner - February 21, 2023

Press Releases | Cancer

Deep Bio’s Novel Study Results Reaffirm Its Global Presence March 14, 2023
USCAP 2023 is Deep Bio’s sixth consecutive year of presenting research abstracts(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/03/prweb19209392.htm
Study Adds Support for Cxbladder Monitor Use in Cancer Surveillance March 14, 2023
Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) welcomes the release of new research supporting the clinical utility of the company’s genomic biomarker test Cxbladder Monitor in the...(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/3/prweb19220555.htm
RSNA: Huge Study Finds Tomosynthesis Better at Breast Cancer Detection March 14, 2023
In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone. The results of the study...(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/rsna_huge_study_finds_tomosynthesis_better_at_breast_cancer_detection/prweb19221463.htm